Off-label drug use and FDA review of supplemental drug applications :  hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996. 

 - 1 online resource (iii, 152 pages) :  illustrations 
<br/><br/> CRDP Program record. 
<br/><br/>Includes bibliographical references. 
<br/><br/><label>Subjects--Corporate Names: </label><br/>United States. Food and Drug Administration --Rules and practice.<br/>United States. Food and Drug Administration. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug utilization--United States.<br/>Drug approval--United States.<br/>Drugs--Labeling--Government policy--United States.<br/>Drugs--Prescribing--United States.<br/>Drugs--Side effects--United States.<br/>Off-Label Use.<br/>Drugs--Labeling.<br/>Drugs--Prescribing.
<br/><br/><label>Subjects--Geographic Terms: </label><br/>United States.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Legislative hearings.
<br/><br/><label>LC Class. No.: </label>KF27  / .G663 1996j 
<br/><br/><label>GPO Item No.: </label>1016-C (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.G 74/7:OF 2/6